LGALS3BP and ovarian carcinoma: In another study, it was found that LGALS3BP and s-IL-2R (soluble form- Interleukin 2 Receptor) serum levels were associated with poor prognosis in a retrospective study on 152 ovarian-cancer patients before primary surgery [38].